Your position:
m.limatoxi.com
>>
EN
>>
EN
>>
Formulation
>>
GlaxoSmithKline Pharmaceuticals Reports 11% Rise in Q1 Profit Driven by Strong Demfor Vaccines
>> article
GlaxoSmithKline Pharmaceuticals Reports 11% Rise in Q1 Profit Driven by Strong Demfor Vaccines
Editor:xuezhe Clicks:
0
Date:2023-8-11 15:49:20
Keyword:
GlaxoSmithKline
Healthoo Information:
GlaxoSmithKline Pharmaceuticals Reports 11% Rise in Q1 Profit Driven by Strong Demfor Vaccines
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
3 billion, nearly 10 years, why GlaxoSmithKline again?
Hong Kong asks GSK to recall paediatric&...
GSK to acquire MeiRui Pharma for $70&nbs...
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
